Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Sharpe HJ"'
Autor:
Young KA; Signalling programme, Babraham Institute, Cambridge CB22 3AT, UK., Wojdyla K; Signalling programme, Babraham Institute, Cambridge CB22 3AT, UK., Lai T; Signalling programme, Babraham Institute, Cambridge CB22 3AT, UK., Mulholland KE; Signalling programme, Babraham Institute, Cambridge CB22 3AT, UK., Aldaz Casanova S; Signalling programme, Babraham Institute, Cambridge CB22 3AT, UK., Antrobus R; Cambridge Institute for Medical Research, Hills Road, Cambridge CB2 0XY, UK., Andrews SR; Bioinformatics, Babraham Institute, Cambridge CB22 3AT, UK., Biggins L; Bioinformatics, Babraham Institute, Cambridge CB22 3AT, UK., Mahler-Araujo B; Histopathology, Cambridge University Hospitals, Cambridge CB2 0QQ, UK., Barton PR; Cambridge Institute for Medical Research, Hills Road, Cambridge CB2 0XY, UK., Anderson KR; Molecular biology department, Genentech, South San Francisco, CA 94080, USA., Fearnley GW; Signalling programme, Babraham Institute, Cambridge CB22 3AT, UK., Sharpe HJ; Signalling programme, Babraham Institute, Cambridge CB22 3AT, UK.
Publikováno v:
Journal of cell science [J Cell Sci] 2024 Jul 15; Vol. 137 (14). Date of Electronic Publication: 2024 Jul 22.
Autor:
Foster WS; Lymphocyte Signalling and Development, Babraham Institute, Babraham Research Campus, Cambridge, UK., Newman J; The Pirbright Institute, Pirbright, Woking, UK., Thakur N; The Pirbright Institute, Pirbright, Woking, UK.; The Jenner Institute, University of Oxford, Oxford, UK., Spencer AJ; Lymphocyte Signalling and Development, Babraham Institute, Babraham Research Campus, Cambridge, UK.; Oxford Vaccine Group, Medical Sciences Division, Department of Paediatrics, University of Oxford and Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK., Davies S; The Jenner Institute, University of Oxford, Oxford, UK., Woods D; Oxford Vaccine Group, Medical Sciences Division, Department of Paediatrics, University of Oxford and Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK., Godfrey L; The Jenner Institute, University of Oxford, Oxford, UK., Ross SH; Lymphocyte Signalling and Development, Babraham Institute, Babraham Research Campus, Cambridge, UK., Sharpe HJ; Signalling Programme, Babraham Institute, Babraham Research Campus, Cambridge, UK., Richard AC; Lymphocyte Signalling and Development, Babraham Institute, Babraham Research Campus, Cambridge, UK., Bailey D; The Pirbright Institute, Pirbright, Woking, UK., Lambe T; The Jenner Institute, University of Oxford, Oxford, UK., Linterman MA; Lymphocyte Signalling and Development, Babraham Institute, Babraham Research Campus, Cambridge, UK.
Publikováno v:
Immunology and cell biology [Immunol Cell Biol] 2023 Jul; Vol. 101 (6), pp. 479-488. Date of Electronic Publication: 2023 May 06.
Autor:
van der Klaauw AA; University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome-Medical Research Council (MRC) Institute of Metabolic Science, University of Cambridge, Cambridge, UK., Horner EC; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Pereyra-Gerber P; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Agrawal U; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Foster WS; Babraham Institute, Babraham Research Campus, Cambridge, UK., Spencer S; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Vergese B; University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome-Medical Research Council (MRC) Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; NIHR Cambridge Clinical Research Facility, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Smith M; University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome-Medical Research Council (MRC) Institute of Metabolic Science, University of Cambridge, Cambridge, UK., Henning E; University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome-Medical Research Council (MRC) Institute of Metabolic Science, University of Cambridge, Cambridge, UK., Ramsay ID; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Smith JA; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Guillaume SM; Babraham Institute, Babraham Research Campus, Cambridge, UK., Sharpe HJ; Babraham Institute, Babraham Research Campus, Cambridge, UK., Hay IM; Babraham Institute, Babraham Research Campus, Cambridge, UK.; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK., Thompson S; Babraham Institute, Babraham Research Campus, Cambridge, UK., Innocentin S; Babraham Institute, Babraham Research Campus, Cambridge, UK., Booth LH; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Robertson C; Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK., McCowan C; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Kerr S; Usher Institute, University of Edinburgh, Edinburgh, UK., Mulroney TE; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., O'Reilly MJ; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Gurugama TP; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Gurugama LP; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Rust MA; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Ferreira A; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Ebrahimi S; Immunology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Clinical Biochemistry, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Ceron-Gutierrez L; Immunology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Clinical Biochemistry, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Scotucci J; University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome-Medical Research Council (MRC) Institute of Metabolic Science, University of Cambridge, Cambridge, UK., Kronsteiner B; Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Dunachie SJ; Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.; NDM Centre for Global Health Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Translational Gastroenterology Unit, University of Oxford, Oxford, UK.; Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand., Klenerman P; Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.; NDM Centre for Global Health Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Translational Gastroenterology Unit, University of Oxford, Oxford, UK., Park AJ; Clinical Biochemistry, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Rubino F; Department of Diabetes, King's College London and King's College Hospital NHS Foundation Trust, London, UK., Lamikanra AA; NHS Blood and Transplant, Oxford, UK.; Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Stark H; NIHR BioResource, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Kingston N; NIHR BioResource, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Estcourt L; NHS Blood and Transplant, Oxford, UK.; Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Harvala H; NHS Blood and Transplant, London, UK., Roberts DJ; NHS Blood and Transplant, Oxford, UK.; Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Doffinger R; Immunology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Clinical Biochemistry, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Linterman MA; Babraham Institute, Babraham Research Campus, Cambridge, UK., Matheson NJ; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; NHS Blood and Transplant, Cambridge, UK., Sheikh A; Usher Institute, University of Edinburgh, Edinburgh, UK. aziz.sheikh@ed.ac.uk., Farooqi IS; University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Wellcome-Medical Research Council (MRC) Institute of Metabolic Science, University of Cambridge, Cambridge, UK. isf20@cam.ac.uk., Thaventhiran JED; MRC Toxicology Unit, University of Cambridge, Cambridge, UK. jedt2@cam.ac.uk.
Publikováno v:
Nature medicine [Nat Med] 2023 May; Vol. 29 (5), pp. 1146-1154. Date of Electronic Publication: 2023 May 11.
Autor:
Hay IM; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom; Signalling Programme, Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom., Shamin M; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom., Caroe ER; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom., Mohammed ASA; European Molecular Biology Laboratory (EMBL) Hamburg Site, Hamburg, Germany., Svergun DI; European Molecular Biology Laboratory (EMBL) Hamburg Site, Hamburg, Germany., Jeffries CM; European Molecular Biology Laboratory (EMBL) Hamburg Site, Hamburg, Germany., Graham SC; Department of Pathology, University of Cambridge, Cambridge, United Kingdom., Sharpe HJ; Signalling Programme, Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom. Electronic address: hayley.sharpe@babraham.ac.uk., Deane JE; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom. Electronic address: jed55@cam.ac.uk.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2023 Jan; Vol. 299 (1), pp. 102750. Date of Electronic Publication: 2022 Nov 25.
Autor:
Foster WS; Lymphocyte Signalling and Development, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK., Lee JL; Lymphocyte Signalling and Development, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK., Thakur N; The Pirbright Institute, Ash Road, Pirbright GU24 0NF, UK; Oxford Vaccine Group, Department of Paediatrics, Medical Sciences Division, University of Oxford and Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), Oxford OX3 7BN, UK., Newman J; The Pirbright Institute, Ash Road, Pirbright GU24 0NF, UK., Spencer AJ; The Jenner Institute, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK., Davies S; Oxford Vaccine Group, Department of Paediatrics, Medical Sciences Division, University of Oxford and Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), Oxford OX3 7BN, UK., Woods D; The Jenner Institute, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK., Godfrey L; The Jenner Institute, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK., Hay IM; Signalling Programme, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK; Cambridge Institute for Medical Research, Hills Road, Cambridge CB2 0XY, UK., Innocentin S; Lymphocyte Signalling and Development, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK., Yam-Puc JC; MRC Toxicology Unit, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK., Horner EC; MRC Toxicology Unit, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK., Sharpe HJ; Signalling Programme, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK., Thaventhiran JE; MRC Toxicology Unit, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK., Bailey D; The Pirbright Institute, Ash Road, Pirbright GU24 0NF, UK., Lambe T; Oxford Vaccine Group, Department of Paediatrics, Medical Sciences Division, University of Oxford and Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), Oxford OX3 7BN, UK. Electronic address: teresa.lambe@paediatrics.ox.ac.uk., Linterman MA; Lymphocyte Signalling and Development, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK. Electronic address: michelle.linterman@babraham.ac.uk.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2022 Dec 20; Vol. 3 (12), pp. 100845. Date of Electronic Publication: 2022 Nov 15.
Autor:
Hay IM; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.; Signalling Programme, Babraham Institute, Cambridge, United Kingdom., Mulholland KE; Signalling Programme, Babraham Institute, Cambridge, United Kingdom., Lai T; Signalling Programme, Babraham Institute, Cambridge, United Kingdom., Graham SC; Department of Pathology, University of Cambridge, Cambridge, United Kingdom., Sharpe HJ; Signalling Programme, Babraham Institute, Cambridge, United Kingdom., Deane JE; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
Publikováno v:
ELife [Elife] 2022 Oct 20; Vol. 11. Date of Electronic Publication: 2022 Oct 20.
Autor:
Yurchenko AA; INSERM U981, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Pop OT; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland., Ighilahriz M; INSERM U976, Hôpital Saint-Louis, Paris, France., Padioleau I; INSERM U981, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Rajabi F; INSERM U981, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Sharpe HJ; Signalling Programme, Babraham Institute, Cambridge, UK., Poulalhon N; Service de dermatologie, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France., Dreno B; Department of Dermato-Oncology, CHU Nantes, Nantes Université, CIC 1413, Inserm UMR 1302/EMR6001 INCIT, F-44000 Nantes, France., Khammari A; Department of Dermato-Oncology, CHU Nantes, Nantes Université, CIC 1413, Inserm UMR 1302/EMR6001 INCIT, F-44000 Nantes, France., Delord M; Université de Paris, Hôpital Saint-Louis, Paris, France.; Department of Population Health Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK., Alberti A; Université de Paris, Hôpital Saint-Louis, Paris, France., Soufir N; INSERM U976, Hôpital Saint-Louis, Paris, France., Battistella M; INSERM U976, Hôpital Saint-Louis, Paris, France.; Université de Paris, Hôpital Saint-Louis, Paris, France.; Service d'anatomie pathologique, Hôpital Saint-Louis, Claude Vellefaux, Paris, France., Mourah S; INSERM U976, Hôpital Saint-Louis, Paris, France.; Université de Paris, Hôpital Saint-Louis, Paris, France.; Département de Génomique des Tumeurs Solides, Hôpital Saint-Louis, Claude Vellefaux, Paris, France., Bouquet F; Institut Roche, Boulogne-Billancourt, France., Savina A; Institut Roche, Boulogne-Billancourt, France., Besse A; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland., Mendez-Lopez M; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland., Grange F; Service de dermatologie, CHU Reims, Rue du general Koenig, Reims, France.; Service de Dermatologie, centre hospitalier de Valence, Valence, France., Monestier S; Service de dermatologie, CHU La Timone, Marseille, France., Mortier L; Service de dermatologie, CHU Lille, Clin Dermato Hop Huriez, Rue Michel Polonovski, Lille, France., Meyer N; Service de dermatologie, Institut Univeristaire du Cancer et CHU de Toulouse, Hôpital Larrey, Toulouse, France., Dutriaux C; Service de dermatologie, CHU Bordeaux, Bordeaux, France., Robert C; INSERM U981, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.; Department of Medical Oncology, Gustave Roussy and Paris-Saclay University, Villejuif, France., Saiag P; Department of General and Oncologic Dermatology, Ambroise-Paré hospital, APHP, and EA 4340 'Biomarkers in Cancerology and Hemato-oncology,' UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France., Herms F; Service de dermatologie, Hôpital Saint-Louis, Paris, France., Lambert J; Université de Paris, Hôpital Saint-Louis, Paris, France.; Service de Biostatistique et Information Médicale, Hôpital Saint-Louis, Paris, France., de Sauvage FJ; Department of Molecular Oncology, Genentech, South San Francisco, California., Dumaz N; INSERM U976, Hôpital Saint-Louis, Paris, France., Flatz L; Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany., Basset-Seguin N; INSERM U976, Hôpital Saint-Louis, Paris, France.; Université de Paris, Hôpital Saint-Louis, Paris, France.; Service de dermatologie, Hôpital Saint-Louis, Paris, France., Nikolaev SI; INSERM U981, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Apr 01; Vol. 28 (7), pp. 1422-1432.
Autor:
Young KA; Signalling Programme, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, U.K., Biggins L; Bioinformatics, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, U.K., Sharpe HJ; Signalling Programme, Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, U.K.
Publikováno v:
The Biochemical journal [Biochem J] 2021 Mar 12; Vol. 478 (5), pp. 1061-1083.
Autor:
Reiterer V; Institute of Basic Medical Sciences, University of Oslo, Norway., Pawłowski K; Institute of Biology, Warsaw University of Life Sciences - SGGW, Poland., Desrochers G; Department of Biochemistry, McGill University, Montréal, QC, Canada.; Goodman Cancer Research Centre, McGill University, Montréal, QC, Canada., Pause A; Department of Biochemistry, McGill University, Montréal, QC, Canada.; Goodman Cancer Research Centre, McGill University, Montréal, QC, Canada., Sharpe HJ; Signalling programme, Babraham Institute, Cambridge, UK., Farhan H; Institute of Basic Medical Sciences, University of Oslo, Norway.
Publikováno v:
The FEBS journal [FEBS J] 2020 Oct; Vol. 287 (19), pp. 4198-4220. Date of Electronic Publication: 2020 Jun 16.
Autor:
Hay IM; Cambridge Institute for Medical Research, Hills Road, Cambridge, CB2 0XY, UK.; Signalling Programme, Babraham Institute, Cambridge, CB22 3AT, UK., Fearnley GW; Cambridge Institute for Medical Research, Hills Road, Cambridge, CB2 0XY, UK.; Signalling Programme, Babraham Institute, Cambridge, CB22 3AT, UK., Rios P; Signalling Research Centres BIOSS and CIBSS, and Faculty of Biology, University of Freiburg, Schänzlestr. 18, Freiburg, D-79104, Germany., Köhn M; Signalling Research Centres BIOSS and CIBSS, and Faculty of Biology, University of Freiburg, Schänzlestr. 18, Freiburg, D-79104, Germany., Sharpe HJ; Cambridge Institute for Medical Research, Hills Road, Cambridge, CB2 0XY, UK. Hayley.sharpe@babraham.ac.uk.; Signalling Programme, Babraham Institute, Cambridge, CB22 3AT, UK. Hayley.sharpe@babraham.ac.uk., Deane JE; Cambridge Institute for Medical Research, Hills Road, Cambridge, CB2 0XY, UK. Jed55@cam.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2020 Jun 26; Vol. 11 (1), pp. 3219. Date of Electronic Publication: 2020 Jun 26.